Sommaire

Numéro précédent | Numéro suivant

• • ·And the beat goes on

    Page :319-320

    Robert A. O'Rourke

    
• • ·Cardiac enzyme elevations after cardiac surgery: The cardiologist's perspective

    Page :321-324

    Kenneth W. Mahaffey, Joseph S. Alpert

    
• • ·Troponin I in cardiac surgery: Marking the future

    Page :325-326

    Mark F. Newman

    
• • ·Need for standardization of noninvasive assessment of vascular endothelial function

    Page :327-328

    Jeffrey T. Kuvin, Ayan R. Patel, Richard H. Karas

    
• • ·Preserved coronary flow reserve in viable myocardium: Further evidence for the microvascular hypothesis

    Page :329-330

    Brad G. Angeja, C.Michael Gibson

    
• • ·Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?

    Page :331-333

    Wendy A. Gattis, Anthony Galanos, Christopher M. O'Connor

    
• • ·Prognostic implications of left ventricular hypertrophy

    Page :334-341

    Babak A. Vakili, Peter M. Okin, Richard B. Devereux

    Résumé Résumé
• • ·Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)—A randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness

    Page :342-347

    Thor T. Markwood, Steven M. Kent, Louis C. Coyle, Patrick J. Flaherty, Patrick G. O'Malley, Allen J. Taylor

    Résumé Résumé
• • ·Dalteparin in combination with abciximab during percutaneous coronary intervention

    Page :348-352

    Dean J. Kereiakes, Neal S. Kleiman, Edward Fry, Grace Mwawasi, Rose Lengerich, Kelly Maresh, Mary Lynn Burkert, Joseph W. Aquilina, Michael DeLoof, Thomas M. Broderick, Thomas M. Shimshak

    Résumé Résumé
• • ·Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: Experience with the AngioJet catheter

    Page :353-359

    Jose A. Silva, Stephen R. Ramee, David J. Cohen, Joseph P. Carrozza, Jeffrey J. Popma, Alexandra A. Lansky, Kim Dandreo, Donald S. Baim, Barry S. George, Daniel J. McCormick, Cindy M. Setum, Richard E. Kuntz

    Résumé Résumé
• • ·A nonischemic electrocardiogram does not always predict a small myocardial infarction: Results with acute myocardial perfusion imaging

    Page :360-366

    Michael C. Kontos, Karen A. Kurdziel, Joseph P. Ornato, Kristin L. Schmidt, Robert L. Jesse, James L. Tatum

    Résumé Résumé
• • ·Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

    Page :367-374

    Alan S. Maisel, Jen Koon, Padma Krishnaswamy, Radmila Kazenegra, Paul Clopton, Nancy Gardetto, Robin Morrisey, Alex Garcia, Albert Chiu, Anthony De Maria

    Résumé Résumé
• • ·Use of electron beam tomography data to develop models for prediction of hard coronary events

    Page :375-382

    Paolo Raggi, Bruce Cooil, Tracy Q. Callister

    Résumé Résumé
• • ·Gated single-photon emission computed tomographic myocardial imaging: A new tool in clinical cardiology

    Page :383-390

    Carine D.L. Bavelaar-Croon, Ernest K.J. Pauwels, Ernst E. van der Wall

    Résumé Résumé
• • ·Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial

    Page :391-401

    Mauricio G. Cohen, Cynthia M. Pacchiana, Ramón Corbalán, Jesús E. Isea Perez, Carlos I. Ponte, Elsa Silva Oropeza, Rafael Diaz, Ernesto Paolasso, Daniel Izasa, Marco A. Rodas, Carlos E. Urrutia, Robert A. Harrington, Eric J. Topol, Robert M. Califf

    Résumé Résumé
• • ·Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) Trial

    Page :402-409

    Résumé Résumé
• • ·Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

    Page :410-417

    Ya-Ting Chen, Yun Wang, Martha J. Radford, Harlan M. Krumholz

    Résumé Résumé
• • ·Effect of metoprolol on cytokine levels in chronic heart failure—A substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)

    Page :418-421

    Lars Gullestad, Thor Ueland, Anne Brunsvig, John Kjekshus, Svein Simonsen, Stig S. Frøland, Pål Aukrust

    Résumé Résumé
• • ·Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading

    Page :422-427

    Hirofumi Tomiyama, Gohki Watanabe, Masayuki Abe, Ryo Okazaki, Hideo Yoshida, Nobutaka Doba

    Résumé Résumé
• • ·Right ventricular diastolic function in β-thalassemia major: Echocardiographic and clinical correlates

    Page :428-434

    George Hahalis, Antonis S. Manolis, Ioanna Gerasimidou, Dimitrios Alexopoulos, George Sitafidis, Alexandra Kourakli, Reiner Körfer, Michael M. Koerner, Apostolos G. Vagenakis, Nikolas C. Zoumbos

    Résumé Résumé
• • ·Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction

    Page :435-438

    Ronald J. Raymond, Gregory J. Dehmer, Theoharis C. Theoharides, Efthymios N. Deliargyris

    Résumé Résumé
• • ·A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: The Strong Heart Study

    Page :439-446

    Richard B. Devereux, Mary J. Roman, Mary Paranicas, Elisa T. Lee, Thomas K. Welty, Richard R. Fabsitz, David Robbins, Everett R. Rhoades, Richard J. Rodeheffer, Linda D. Cowan, Barbara V. Howard

    Résumé Résumé
• • ·Usefulness of cardiac troponin I in patients undergoing open heart surgery

    Page :447-455

    Nikolas Greenson, John Macoviak, Padma Krishnaswamy, Robin Morrisey, Cherimarie James, Paul Clopton, Robert Fitzgerald, Alan S. Maisel

    Résumé Résumé
• • ·Relationship between extent of residual myocardial viability and coronary flow reserve in patients with recent myocardial infarction

    Page :456-462

    Michael Ragosta, Eric R. Powers, Habib Samady, Lawrence W. Gimple, Ian J. Sarembock, George A. Beller

    Résumé Résumé
• • ·Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project

    Page :463-468

    Allen J. Taylor, Irwin Feuerstein, Henry Wong, William Barko, Michael Brazaitis, Patrick G. O'Malley

    Résumé Résumé
• • ·Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy

    Page :469-477

    Marino Labinaz, Michael H. Sketch, Stephen G. Ellis, Bruce M. Abramowitz, Amanda L. Stebbins, Karen S. Pieper, David R. Holmes, Robert M. Califf, Eric J. Topol, for the GUSTO-I Investigators

    Résumé Résumé
• • ·Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era—A national study

    Page :478-484

    Avraham Shotan, Shmuel Gottlieb, Uri Goldbourt, Valentina Boyko, Henrietta Reicher-Reiss, Michael Arad, Lori Mandelzweig, Hanoch Hod, Elieser Kaplinsky, Solomon Behar, for the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group and the Israeli Thrombolytic Survey Group

    Résumé Résumé
• • ·Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: A marker for a worse prognosis

    Page :485-490

    Enrique Z. Fisman, Michael Motro, Alexander Tenenbaum, Valentina Boyko, Lori Mandelzweig, Solomon Behar

    Résumé Résumé
• • ·Congenital left ventricular aneurysm: Clinical, imaging, pathologic, and surgical findings in seven new cases

    Page :491-499

    John Papagiannis, Richard Van Praagh, Oscar Schwint, Luigi D'Orsogna, Faisal Qureshi, James Reynolds, Carlo Kallfelz, Jose Nozar

    Résumé Résumé
• • ·Estimation of pressure gradients by auscultation: An innovative and accurate physical examination technique

    Page :500-506

    Colin K.L. Phoon

    Résumé Résumé